XML 26 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivative Instruments
9 Months Ended
Sep. 30, 2022
Derivative Instruments  
Derivative Instruments

Note 5. Derivative Instruments

The Company enters into derivative instruments to manage risk, primarily equity, interest rate, credit, foreign currency and market volatility. The derivative instruments are to hedge fixed indexed annuity products that guarantee the return of principal to the policyholders and credit interest based on a percentage of the gain in a specified market index. To hedge against adverse changes in equity indices, the Company entered into contracts to buy equity indexed options.

​

The following is a summary of the asset derivatives not designated as hedges embedded in our FIA product as of September 30, 2022, and December 31, 2021:  

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

September 30, 2022

​

December 31, 2021

​

​

Location in the

​

​

​

​

​

​

​

​

​

​

​

(In thousands, except number of contracts)

​

Consolidated

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Derivatives Not Designated

​

Statement of

Notional

​

Number of

​

Estimated

​

Notional

​

Number of

​

Estimated

as Hedging Instruments

​

Balance Sheets

Amount

​

Contracts

​

Fair Value

​

Amount

​

Contracts

​

Fair Value

Equity-indexed options

​

Derivatives

$

869,504

​

594

​

$

11,840

​

$

526,096

​

482

​

$

23,766

Equity-indexed
embedded derivatives

​

Deposit-type
contracts

​

729,352

​

5,689

​

​

120,835

​

​

525,548

​

4,205

​

​

123,692

​

At September 30, 2022, the value of the embedded derivative considers all amounts projected to be paid in excess of the minimum guarantee (the amounts payable without any indexation increases) over future periods. The host contract reflects the minimum guaranteed values.

​

Due to Federal Reserve rate increases, our securities positions resulted in unrealized losses at September 30, 2022, and December 31, 2021, reported in accumulated other comprehensive income on the balance sheet. The embedded derivative related to the asset portfolio belonging to the third-party reinsurers offset these unrealized losses. The unrealized losses as of September 30, 2022, were $14.4 million compared to unrealized gains of $0.2 million as of December 31, 2021.

The following table summarizes the impact of those embedded derivatives related to the FW provision where the total return on the asset portfolio is passed through to the third-party reinsurers:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

September 30, 2022

​

December 31, 2021

(In thousands)

​

Book Value

​

Market Value

​

Total Return

​

Book Value

​

Market Value

​

Total Return

Portfolio

​

Assets

​

Assets

​

Swap Value

​

Assets

​

Assets

​

Swap Value

American Republic Insurance Company

​

$

137,868

​

$

132,715

​

$

5,153

​

$

74,983

​

$

74,670

​

$

313

Crestline Re SP1

​

​

293,483

​

​

292,013

​

​

1,470

​

​

228,560

​

​

228,450

​

​

110

Ironbound

​

​

162,941

​

​

157,655

​

​

5,286

​

​

154,867

​

​

155,755

​

​

(888)

Ascendent Re

​

​

56,405

​

​

55,013

​

​

1,392

​

​

56,246

​

​

56,078

​

​

168

SRC4

​

​

21,947

​

​

21,947

​

​

-

​

​

​

​

​

​

​

​

​

US Alliance

​

​

47,202

​

​

46,064

​

​

1,138

​

​

46,221

​

​

46,085

​

​

136

Total

​

$

719,846

​

$

705,407

​

$

14,439

​

$

560,877

​

$

561,038

​

$

(161)

​

Assets carried as investments on American Life’s financial statements for the third-party reinsurers contained cumulative unrealized losses of approximately $14.4 million as of September 30, 2022, and cumulative unrealized gains of $0.2 million as of December 31, 2021, respectively. The terms of the contracts with the third-party reinsurers provide that the changes in unrealized gains on the portfolios accrue to the third-party reinsurers. Accordingly, the change in unrealized losses on the assets held by American Life were offset by gains in the embedded derivative of $14.6 million and a gain in the embedded derivative of $0.9 million as of September 30, 2022, and 2021, respectively. We account for this unrealized (loss) pass-through by recording an equivalent realized gain on our Consolidated Statements of Comprehensive Loss and in amounts payable to our third-party reinsurers on the Consolidated Balance Sheets.